X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (40760) 40760
Newsletter (994) 994
Book Chapter (160) 160
Newspaper Article (88) 88
Magazine Article (58) 58
Publication (24) 24
Dissertation (18) 18
Book Review (15) 15
Reference (5) 5
Conference Proceeding (3) 3
Book / eBook (2) 2
Transcript (2) 2
Government Document (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (20578) 20578
animals (19648) 19648
humans (19491) 19491
index medicus (14449) 14449
female (11721) 11721
rats (11695) 11695
angiotensin (9629) 9629
hypertension (9219) 9219
blood pressure - drug effects (8254) 8254
middle aged (6970) 6970
pharmacology & pharmacy (5988) 5988
angiotensin-ii (5670) 5670
adult (5475) 5475
hypertension - drug therapy (5446) 5446
aged (5206) 5206
angiotensin-converting enzyme inhibitors - therapeutic use (5072) 5072
angiotensin ii (5060) 5060
peripheral vascular disease (5000) 5000
blood pressure (4804) 4804
angiotensin ii - pharmacology (4517) 4517
renin-angiotensin system (4452) 4452
cardiac & cardiovascular systems (4410) 4410
blood-pressure (4401) 4401
physiology (4186) 4186
hypertension - physiopathology (3727) 3727
rats, sprague-dawley (3645) 3645
angiotensin-converting enzyme inhibitors - administration & dosage (3558) 3558
mice (3495) 3495
dose-response relationship, drug (3394) 3394
research (3238) 3238
angiotensin-converting enzyme inhibitors - pharmacology (3170) 3170
renin-angiotensin system - drug effects (3126) 3126
oxidative stress (2974) 2974
treatment outcome (2886) 2886
time factors (2873) 2873
urology & nephrology (2666) 2666
heart failure (2662) 2662
antihypertensive agents - therapeutic use (2652) 2652
expression (2652) 2652
risk factors (2603) 2603
drug therapy, combination (2574) 2574
rats, wistar (2573) 2573
disease models, animal (2546) 2546
renin - blood (2369) 2369
enzymes (2298) 2298
physiological aspects (2205) 2205
mortality (2163) 2163
analysis (2127) 2127
renin (2085) 2085
drug therapy (2072) 2072
antihypertensive agents - administration & dosage (2057) 2057
angiotensin-converting enzyme (2055) 2055
heart failure - drug therapy (2024) 2024
captopril (2018) 2018
losartan (2003) 2003
angiotensin ii - administration & dosage (1996) 1996
medicine & public health (1993) 1993
heart rate - drug effects (1985) 1985
rodents (1949) 1949
antihypertensive agents - pharmacology (1945) 1945
health aspects (1934) 1934
endocrinology & metabolism (1927) 1927
angiotensin receptor antagonists (1852) 1852
inflammation (1851) 1851
kidney - drug effects (1848) 1848
renin-angiotensin system - physiology (1842) 1842
diabetes (1825) 1825
inhibition (1815) 1815
ace inhibitors (1787) 1787
double-blind method (1757) 1757
aldosterone (1754) 1754
care and treatment (1746) 1746
medicine, research & experimental (1664) 1664
angiotensin ii - metabolism (1662) 1662
medicine, general & internal (1647) 1647
heart-failure (1643) 1643
system (1630) 1630
hemodynamics - drug effects (1610) 1610
nitric oxide (1602) 1602
angiotensin-converting enzyme inhibitors (1579) 1579
fibrosis (1572) 1572
neurosciences (1563) 1563
blood pressure - physiology (1550) 1550
heart (1550) 1550
angiotensin ii type 1 receptor blockers - therapeutic use (1542) 1542
rats, inbred shr (1527) 1527
nitric-oxide (1524) 1524
cardiology (1514) 1514
medicine (1514) 1514
angiotensin-converting enzyme inhibitors - adverse effects (1511) 1511
activation (1498) 1498
biochemistry & molecular biology (1493) 1493
kidney (1478) 1478
dosage and administration (1472) 1472
tetrazoles - pharmacology (1447) 1447
enalapril (1441) 1441
disease (1414) 1414
internal medicine (1397) 1397
dogs (1394) 1394
captopril - pharmacology (1389) 1389
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (40806) 40806
Japanese (521) 521
Russian (338) 338
German (263) 263
French (186) 186
Spanish (85) 85
Italian (80) 80
Chinese (75) 75
Polish (65) 65
Danish (35) 35
Hungarian (33) 33
Czech (27) 27
Portuguese (26) 26
Swedish (26) 26
Norwegian (22) 22
Korean (18) 18
Ukrainian (16) 16
Romanian (9) 9
Dutch (7) 7
Finnish (6) 6
Lithuanian (6) 6
Turkish (6) 6
Hebrew (5) 5
Slovak (5) 5
Bulgarian (4) 4
Croatian (3) 3
Serbian (3) 3
Bosnian (2) 2
Persian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The American journal of medicine, ISSN 0002-9343, 2012, Volume 125, Issue 9, pp. 882 - 887.e1
Abstract Objective Combination therapy, specifically with aspirin, cholesterol and blood pressure-lowering drugs, substantially reduces the risk of coronary... 
Internal Medicine | Adherence | Prevention | Cardiovascular disease | PERSISTENCE | ACUTE CORONARY SYNDROMES | CONVERTING ENZYME-INHIBITORS | SECONDARY PREVENTION | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | STATIN THERAPY | ACUTE MYOCARDIAL-INFARCTION | BETA-BLOCKERS | MEDICATION ADHERENCE | ARTERY-DISEASE | Drug Costs | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Medication Adherence - statistics & numerical data | Cardiovascular Agents - administration & dosage | Age Factors | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Antihypertensive Agents - administration & dosage | Secondary Prevention - methods | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Aspirin - administration & dosage | Drug Prescriptions - statistics & numerical data | Self Administration | Time Factors | Anticholesteremic Agents - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Calcium Channel Blockers - administration & dosage | Primary Prevention - methods | Sodium Chloride Symporter Inhibitors - administration & dosage | Myocardial Infarction - prevention & control | Adrenergic beta-Antagonists - administration & dosage | Angiotensin Receptor Antagonists - administration & dosage | Research | Patient compliance | Coronary heart disease | Drugs | Myocardial infarction | Aspirin | Side effects | Enzyme inhibitors | Risk reduction | Age | Statins
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2005, Volume 366, Issue 9489, pp. 895 - 906
The apparent shortfall in prevention of coronary heart disease (CHD) noted in early hypertension trials has been attributed to disadvantages of the diuretics... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | MANAGEMENT | MORBIDITY | DISEASE | GUIDELINES | DOUBLE-BLIND | CALCIUM-ANTAGONISTS | HYPERTENSION | INTERVENTION | Calcium Channel Blockers - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Bendroflumethiazide - administration & dosage | Hypertension - drug therapy | Male | Perindopril - administration & dosage | Sodium Chloride Symporter Inhibitors - administration & dosage | Diuretics | Adrenergic beta-Antagonists - adverse effects | Adult | Female | Blood Pressure - drug effects | Atenolol - administration & dosage | Drug Therapy, Combination | Amlodipine - administration & dosage | Adrenergic beta-Antagonists - administration & dosage | Risk Factors | Amlodipine - adverse effects | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Antihypertensive Agents - adverse effects | Coronary Disease - prevention & control | Calcium Channel Blockers - administration & dosage | Atenolol - adverse effects | Hypertension - complications | Aged | Hypertension | Antihypertensive drugs | Evaluation | Dosage and administration | Drug therapy | Prevention | Drug therapy, Combination | Health aspects | Coronary heart disease | Risk factors | Studies | Drugs | Cardiovascular disease | Medical treatment | Myocardial infarction | Heart attacks | Antihypertensives | Clinical trials | Family medical history | Evidence-based medicine | Blood | Randomization | Motivation | Blood pressure | Heart diseases | Antihypertensive agents | Cerebral infarction | Stroke | Fasting | Mortality | Diabetes mellitus | Health risks | Triglycerides | Metabolism | Risk analysis | Atenolol | Patients | Coronary artery disease | Cholesterol | Heart rate | Infarction | Diabetes | Cardiovascular diseases | Health risk assessment | Potassium | Amlodipine/administration & dosage/adverse effects | Bendroflumethiazide/administration & dosage | Cardiovascular Diseases/prevention & control | Perindopril/administration & dosage | MEDICIN OCH HÄLSOVETENSKAP | Atenolol/administration & dosage/adverse effects | Combination | Antihypertensive Agents/administration & dosage/adverse effects | Angiotensin-Converting Enzyme Inhibitors/administration & dosage | MEDICAL AND HEALTH SCIENCES | Coronary Disease/prevention & control | Drug Therapy | Adrenergic beta-Antagonists/administration & dosage/adverse effects | Blood Pressure/drug effects | Hypertension/complications/drug therapy | Calcium Channel Blockers/administration & dosage/adverse effects | Sodium Chloride Symporter Inhibitors/administration & dosage
Journal Article
Experimental physiology, ISSN 0958-0670, 2018, Volume 103, Issue 6, pp. 916 - 923
Journal Article
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 08/2005, Volume 7, Issue 5, pp. 710 - 721
Surveys of prescribing patterns in both hospitals and primary care have usually shown delays in translating the evidence from clinical trials of... 
Heart failure | Isosorbide dinitrate | Beta‐blockers | Digoxin | Angiotensin receptor blockers | Pharmacology | Aldosterone antagonists | Treatment | Eplerenone | Spironolactone | Hydralazine | ACE inhibitors | Clinical recommendations | Beta-blockers | VENTRICULAR SYSTOLIC DYSFUNCTION | heart failure | treatment | CARDIAC & CARDIOVASCULAR SYSTEMS | angiotensin receptor blockers | QUALITY-OF-CARE | hydralazine | eplerenone | isosorbide dinitrate | RANDOMIZED INTERVENTION TRIAL | beta-blockers | MEDICAL-TREATMENT | GENERAL-PRACTICE | digoxin | spironolactone | CONVERTING-ENZYME-INHIBITORS | clinical recommendations | CARDIAC-INSUFFICIENCY | pharmacology | NATIONAL-SURVEY | aldosterone antagonists | ELDERLY-PATIENTS | Benzopyrans - therapeutic use | Valsartan | Angiotensin Receptor Antagonists | Bisoprolol - therapeutic use | Humans | Carbazoles - administration & dosage | Heart Failure - physiopathology | Valine - administration & dosage | Enalapril - therapeutic use | Ethanolamines - administration & dosage | Indoles - administration & dosage | Ramipril - administration & dosage | Captopril - therapeutic use | Propanolamines - therapeutic use | Lisinopril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Benzimidazoles - administration & dosage | Tetrazoles - administration & dosage | Ramipril - therapeutic use | Drug Therapy, Combination | Enalapril - administration & dosage | Spironolactone - therapeutic use | Adrenergic beta-Antagonists - administration & dosage | Adrenergic beta-Antagonists - therapeutic use | Benzimidazoles - therapeutic use | Lisinopril - administration & dosage | Nebivolol | Valine - analogs & derivatives | Metoprolol - therapeutic use | Metoprolol - administration & dosage | Evidence-Based Medicine | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Bisoprolol - administration & dosage | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Stroke Volume | Benzopyrans - administration & dosage | Captopril - administration & dosage | Guideline Adherence | Ethanolamines - therapeutic use | Indoles - therapeutic use | Metoprolol - analogs & derivatives | Tetrazoles - therapeutic use | Valine - therapeutic use | Carbazoles - therapeutic use | Propanolamines - administration & dosage | Practice Guidelines as Topic | Prescription writing | Corticosteroids | Isosorbide mononitrate | Family medicine | Nitrates | Peptide hormones | Aldosterone | Preventive health services | Cardiac patients | Angiotensin | Antiandrogens | Medicine, Preventive | Steroids | Kardiologi | converting-enzyme-inhibitors | Cardiac and Cardiovascular Systems | randomized intervention trial | quality-of-care | elderly-patients | cardiac-insufficiency | national-survey | medical-treatment | ventricular systolic dysfunction | general-practice
Journal Article
Journal of molecular medicine (Berlin, Germany), ISSN 1432-1440, 2013, Volume 92, Issue 3, pp. 255 - 265
...ORIGINAL ARTICLE Oral administration of angiotensin-(1–7) ameliorates type 2 diabetes in rats Sérgio H. S. Santos & Jorge F. Giani & Valeria Burghi & Johanna G... 
Human Genetics | Biomedicine | RNA interference | Angiotensin-(1–7) | Antidiabetic | Internal Medicine | Molecular Medicine | Diabetes | Angiotensin-(1-7) | SYSTEM | MEDICINE, RESEARCH & EXPERIMENTAL | METABOLIC SYNDROME | ACTIVATION | PHOSPHORYLATION | GLUCOSE-HOMEOSTASIS | GENETICS & HEREDITY | NITRIC-OXIDE | RESISTANCE | HYPERTENSION |